Home-Based Testing Firm EverlyWell Raises $50M

Apr 16, 2019

|

NEW YORK (360Dx) – Home-based testing firm EverlyWell today announced it had raised $50 million to expand its digital platform and scale existing partnerships with companies including CVS and Humana.

The financing was led by existing investor Goodwater Capital. Highland Capital Partners also participated in the financing.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Home-Based Testing Firm EverlyWell Raises $50M

To read the full story....

Breaking News

Thermo Fisher Scientific, First Genetics to Develop NGS-Based Diagnostics in Russia

Novacyt Reports Sharp Increase in Preliminary H1 Revenues

Quest Reports Preliminary Q2 Revenues of $1.83B

Vela Diagnostics Automated Coronavirus Test Gets CE-IVD Mark

OpGen to Distribute Menarini Silicon Cellsearch Platform in North America for COVID-19 Applications

Paige Secures Additional $15M, Bringing Total Series B Funding to $70M

What's Popular?

FDA Grants EUA for UCSF, Broad Institute, BioSewoom Coronavirus Tests

Thermo Fisher Scientific, First Genetics to Develop NGS-Based Diagnostics in Russia

Paige Secures Additional $15M, Bringing Total Series B Funding to $70M

Novacyt Reports Sharp Increase in Preliminary H1 Revenues

Amid Interest Generated by Coronavirus Testing, IPO Window Open for Dx Firms in 2020

Sponsorships